Barclays analyst Matt Miksic upgraded Medtronic to Overweight from Equal Weight with a $104 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MDT:
- Medtronic Gains Ground Following Analyst Praise
- Wells Fargo upgrades Medtronic to Overweight, raises price target to $100
- Medtronic upgraded to Overweight from Equal Weight at Wells Fargo
- Medtronic announces FDA approval of MiniMed 780G system
- Tandem Diabetes down 5% after FDA approves Medtronic’s MiniMed 780G